nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Eye pruritus—Pamidronate—Paget's disease of bone	0.0238	0.0238	CcSEcCtD
Apraclonidine—Endophthalmitis—Risedronate—Paget's disease of bone	0.0235	0.0235	CcSEcCtD
Apraclonidine—Ocular hyperaemia—Zoledronate—Paget's disease of bone	0.0207	0.0207	CcSEcCtD
Apraclonidine—Endophthalmitis—Zoledronate—Paget's disease of bone	0.0204	0.0204	CcSEcCtD
Apraclonidine—Rhinitis—Tiludronate—Paget's disease of bone	0.0172	0.0172	CcSEcCtD
Apraclonidine—Rhinorrhoea—Pamidronate—Paget's disease of bone	0.0131	0.0131	CcSEcCtD
Apraclonidine—Myalgia—Tiludronate—Paget's disease of bone	0.0127	0.0127	CcSEcCtD
Apraclonidine—Inflammation—Risedronate—Paget's disease of bone	0.0115	0.0115	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.0111	0.0111	CcSEcCtD
Apraclonidine—Inflammation—Pamidronate—Paget's disease of bone	0.0109	0.0109	CcSEcCtD
Apraclonidine—Pain—Tiludronate—Paget's disease of bone	0.0104	0.0104	CcSEcCtD
Apraclonidine—Dry eye—Risedronate—Paget's disease of bone	0.0103	0.0103	CcSEcCtD
Apraclonidine—Asthma—Etidronic acid—Paget's disease of bone	0.0103	0.0103	CcSEcCtD
Apraclonidine—Inflammation—Zoledronate—Paget's disease of bone	0.01	0.01	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00995	0.00995	CcSEcCtD
Apraclonidine—Abdominal pain—Tiludronate—Paget's disease of bone	0.00962	0.00962	CcSEcCtD
Apraclonidine—Asthma—Alendronate—Paget's disease of bone	0.00874	0.00874	CcSEcCtD
Apraclonidine—Asthenia—Tiludronate—Paget's disease of bone	0.00873	0.00873	CcSEcCtD
Apraclonidine—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00837	0.00837	CcSEcCtD
Apraclonidine—Diarrhoea—Tiludronate—Paget's disease of bone	0.00833	0.00833	CcSEcCtD
Apraclonidine—Dizziness—Tiludronate—Paget's disease of bone	0.00805	0.00805	CcSEcCtD
Apraclonidine—Eye pain—Zoledronate—Paget's disease of bone	0.0078	0.0078	CcSEcCtD
Apraclonidine—Headache—Tiludronate—Paget's disease of bone	0.00763	0.00763	CcSEcCtD
Apraclonidine—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00725	0.00725	CcSEcCtD
Apraclonidine—Nausea—Tiludronate—Paget's disease of bone	0.00723	0.00723	CcSEcCtD
Apraclonidine—Erythema—Etidronic acid—Paget's disease of bone	0.00714	0.00714	CcSEcCtD
Apraclonidine—Asthma—Risedronate—Paget's disease of bone	0.00701	0.00701	CcSEcCtD
Apraclonidine—Haemorrhage—Alendronate—Paget's disease of bone	0.00699	0.00699	CcSEcCtD
Apraclonidine—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00689	0.00689	CcSEcCtD
Apraclonidine—Oedema peripheral—Alendronate—Paget's disease of bone	0.00689	0.00689	CcSEcCtD
Apraclonidine—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00672	0.00672	CcSEcCtD
Apraclonidine—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.0063	0.0063	CcSEcCtD
Apraclonidine—Infestation NOS—Risedronate—Paget's disease of bone	0.00625	0.00625	CcSEcCtD
Apraclonidine—Infestation—Risedronate—Paget's disease of bone	0.00625	0.00625	CcSEcCtD
Apraclonidine—Erythema—Alendronate—Paget's disease of bone	0.00609	0.00609	CcSEcCtD
Apraclonidine—Asthma—Zoledronate—Paget's disease of bone	0.00609	0.00609	CcSEcCtD
Apraclonidine—Conjunctivitis—Risedronate—Paget's disease of bone	0.00607	0.00607	CcSEcCtD
Apraclonidine—Discomfort—Etidronic acid—Paget's disease of bone	0.00601	0.00601	CcSEcCtD
Apraclonidine—Dysgeusia—Alendronate—Paget's disease of bone	0.00596	0.00596	CcSEcCtD
Apraclonidine—Infestation NOS—Pamidronate—Paget's disease of bone	0.00594	0.00594	CcSEcCtD
Apraclonidine—Infestation—Pamidronate—Paget's disease of bone	0.00594	0.00594	CcSEcCtD
Apraclonidine—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00583	0.00583	CcSEcCtD
Apraclonidine—Infection—Etidronic acid—Paget's disease of bone	0.00579	0.00579	CcSEcCtD
Apraclonidine—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00577	0.00577	CcSEcCtD
Apraclonidine—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00565	0.00565	CcSEcCtD
Apraclonidine—Rhinitis—Risedronate—Paget's disease of bone	0.00562	0.00562	CcSEcCtD
Apraclonidine—Haemorrhage—Risedronate—Paget's disease of bone	0.00561	0.00561	CcSEcCtD
Apraclonidine—Pharyngitis—Risedronate—Paget's disease of bone	0.00557	0.00557	CcSEcCtD
Apraclonidine—Oedema peripheral—Risedronate—Paget's disease of bone	0.00553	0.00553	CcSEcCtD
Apraclonidine—Malaise—Alendronate—Paget's disease of bone	0.00549	0.00549	CcSEcCtD
Apraclonidine—Infestation NOS—Zoledronate—Paget's disease of bone	0.00543	0.00543	CcSEcCtD
Apraclonidine—Infestation—Zoledronate—Paget's disease of bone	0.00543	0.00543	CcSEcCtD
Apraclonidine—Rhinitis—Pamidronate—Paget's disease of bone	0.00535	0.00535	CcSEcCtD
Apraclonidine—Haemorrhage—Pamidronate—Paget's disease of bone	0.00533	0.00533	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00531	0.00531	CcSEcCtD
Apraclonidine—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00527	0.00527	CcSEcCtD
Apraclonidine—Eye disorder—Risedronate—Paget's disease of bone	0.00524	0.00524	CcSEcCtD
Apraclonidine—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00523	0.00523	CcSEcCtD
Apraclonidine—Chest pain—Alendronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Apraclonidine—Myalgia—Alendronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Apraclonidine—Discomfort—Alendronate—Paget's disease of bone	0.00512	0.00512	CcSEcCtD
Apraclonidine—Angiopathy—Risedronate—Paget's disease of bone	0.00509	0.00509	CcSEcCtD
Apraclonidine—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00506	0.00506	CcSEcCtD
Apraclonidine—Arrhythmia—Risedronate—Paget's disease of bone	0.00501	0.00501	CcSEcCtD
Apraclonidine—Constipation—Etidronic acid—Paget's disease of bone	0.00499	0.00499	CcSEcCtD
Apraclonidine—Eye disorder—Pamidronate—Paget's disease of bone	0.00498	0.00498	CcSEcCtD
Apraclonidine—Bradycardia—Zoledronate—Paget's disease of bone	0.00496	0.00496	CcSEcCtD
Apraclonidine—Infection—Alendronate—Paget's disease of bone	0.00494	0.00494	CcSEcCtD
Apraclonidine—Mental disorder—Risedronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Apraclonidine—Angiopathy—Pamidronate—Paget's disease of bone	0.00484	0.00484	CcSEcCtD
Apraclonidine—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00481	0.00481	CcSEcCtD
Apraclonidine—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.0048	0.0048	CcSEcCtD
Apraclonidine—Oedema peripheral—Zoledronate—Paget's disease of bone	0.0048	0.0048	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00477	0.00477	CcSEcCtD
Apraclonidine—Erythema—Pamidronate—Paget's disease of bone	0.00464	0.00464	CcSEcCtD
Apraclonidine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00461	0.00461	CcSEcCtD
Apraclonidine—Tension—Pamidronate—Paget's disease of bone	0.00456	0.00456	CcSEcCtD
Apraclonidine—Eye disorder—Zoledronate—Paget's disease of bone	0.00455	0.00455	CcSEcCtD
Apraclonidine—Dysgeusia—Pamidronate—Paget's disease of bone	0.00455	0.00455	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Apraclonidine—Nervousness—Pamidronate—Paget's disease of bone	0.00451	0.00451	CcSEcCtD
Apraclonidine—Angiopathy—Zoledronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Apraclonidine—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00439	0.00439	CcSEcCtD
Apraclonidine—Syncope—Risedronate—Paget's disease of bone	0.00438	0.00438	CcSEcCtD
Apraclonidine—Arrhythmia—Zoledronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Apraclonidine—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00431	0.00431	CcSEcCtD
Apraclonidine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Apraclonidine—Mental disorder—Zoledronate—Paget's disease of bone	0.00427	0.00427	CcSEcCtD
Apraclonidine—Constipation—Alendronate—Paget's disease of bone	0.00425	0.00425	CcSEcCtD
Apraclonidine—Pain—Alendronate—Paget's disease of bone	0.00425	0.00425	CcSEcCtD
Apraclonidine—Erythema—Zoledronate—Paget's disease of bone	0.00424	0.00424	CcSEcCtD
Apraclonidine—Malaise—Pamidronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Apraclonidine—Syncope—Pamidronate—Paget's disease of bone	0.00416	0.00416	CcSEcCtD
Apraclonidine—Chest pain—Risedronate—Paget's disease of bone	0.00416	0.00416	CcSEcCtD
Apraclonidine—Myalgia—Risedronate—Paget's disease of bone	0.00416	0.00416	CcSEcCtD
Apraclonidine—Dysgeusia—Zoledronate—Paget's disease of bone	0.00415	0.00415	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00413	0.00413	CcSEcCtD
Apraclonidine—Pruritus—Etidronic acid—Paget's disease of bone	0.00412	0.00412	CcSEcCtD
Apraclonidine—Feeling abnormal—Alendronate—Paget's disease of bone	0.00409	0.00409	CcSEcCtD
Apraclonidine—Dry mouth—Risedronate—Paget's disease of bone	0.00407	0.00407	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Apraclonidine—Vision blurred—Zoledronate—Paget's disease of bone	0.004	0.004	CcSEcCtD
Apraclonidine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00399	0.00399	CcSEcCtD
Apraclonidine—Infection—Risedronate—Paget's disease of bone	0.00396	0.00396	CcSEcCtD
Apraclonidine—Myalgia—Pamidronate—Paget's disease of bone	0.00395	0.00395	CcSEcCtD
Apraclonidine—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Apraclonidine—Abdominal pain—Alendronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Apraclonidine—Nervous system disorder—Risedronate—Paget's disease of bone	0.00391	0.00391	CcSEcCtD
Apraclonidine—Discomfort—Pamidronate—Paget's disease of bone	0.00391	0.00391	CcSEcCtD
Apraclonidine—Skin disorder—Risedronate—Paget's disease of bone	0.00387	0.00387	CcSEcCtD
Apraclonidine—Malaise—Zoledronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Apraclonidine—Syncope—Zoledronate—Paget's disease of bone	0.0038	0.0038	CcSEcCtD
Apraclonidine—Oedema—Pamidronate—Paget's disease of bone	0.00379	0.00379	CcSEcCtD
Apraclonidine—Infection—Pamidronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Apraclonidine—Palpitations—Zoledronate—Paget's disease of bone	0.00375	0.00375	CcSEcCtD
Apraclonidine—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00372	0.00372	CcSEcCtD
Apraclonidine—Vomiting—Etidronic acid—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Apraclonidine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Apraclonidine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00366	0.00366	CcSEcCtD
Apraclonidine—Headache—Etidronic acid—Paget's disease of bone	0.00365	0.00365	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00363	0.00363	CcSEcCtD
Apraclonidine—Myalgia—Zoledronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Apraclonidine—Chest pain—Zoledronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Apraclonidine—Insomnia—Risedronate—Paget's disease of bone	0.0036	0.0036	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Apraclonidine—Paraesthesia—Risedronate—Paget's disease of bone	0.00358	0.00358	CcSEcCtD
Apraclonidine—Discomfort—Zoledronate—Paget's disease of bone	0.00357	0.00357	CcSEcCtD
Apraclonidine—Asthenia—Alendronate—Paget's disease of bone	0.00356	0.00356	CcSEcCtD
Apraclonidine—Dyspnoea—Risedronate—Paget's disease of bone	0.00355	0.00355	CcSEcCtD
Apraclonidine—Dry mouth—Zoledronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Apraclonidine—Pruritus—Alendronate—Paget's disease of bone	0.00351	0.00351	CcSEcCtD
Apraclonidine—Nausea—Etidronic acid—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Apraclonidine—Oedema—Zoledronate—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00345	0.00345	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Apraclonidine—Infection—Zoledronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Apraclonidine—Fatigue—Risedronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Apraclonidine—Insomnia—Pamidronate—Paget's disease of bone	0.00343	0.00343	CcSEcCtD
Apraclonidine—Pain—Risedronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Apraclonidine—Constipation—Risedronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Apraclonidine—Paraesthesia—Pamidronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Apraclonidine—Diarrhoea—Alendronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Apraclonidine—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00339	0.00339	CcSEcCtD
Apraclonidine—Dyspnoea—Pamidronate—Paget's disease of bone	0.00338	0.00338	CcSEcCtD
Apraclonidine—Somnolence—Pamidronate—Paget's disease of bone	0.00337	0.00337	CcSEcCtD
Apraclonidine—Skin disorder—Zoledronate—Paget's disease of bone	0.00336	0.00336	CcSEcCtD
Apraclonidine—Dizziness—Alendronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00327	0.00327	CcSEcCtD
Apraclonidine—Fatigue—Pamidronate—Paget's disease of bone	0.00327	0.00327	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Apraclonidine—Constipation—Pamidronate—Paget's disease of bone	0.00324	0.00324	CcSEcCtD
Apraclonidine—Pain—Pamidronate—Paget's disease of bone	0.00324	0.00324	CcSEcCtD
Apraclonidine—Vomiting—Alendronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00315	0.00315	CcSEcCtD
Apraclonidine—Abdominal pain—Risedronate—Paget's disease of bone	0.00315	0.00315	CcSEcCtD
Apraclonidine—Insomnia—Zoledronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Apraclonidine—Dermatitis—Alendronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Apraclonidine—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Apraclonidine—Headache—Alendronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Apraclonidine—Paraesthesia—Zoledronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Apraclonidine—Dyspnoea—Zoledronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Apraclonidine—Somnolence—Zoledronate—Paget's disease of bone	0.00308	0.00308	CcSEcCtD
Apraclonidine—Abdominal pain—Pamidronate—Paget's disease of bone	0.003	0.003	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00299	0.00299	CcSEcCtD
Apraclonidine—Fatigue—Zoledronate—Paget's disease of bone	0.00298	0.00298	CcSEcCtD
Apraclonidine—Pain—Zoledronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Apraclonidine—Constipation—Zoledronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Apraclonidine—Nausea—Alendronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
Apraclonidine—Hypersensitivity—Risedronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Apraclonidine—Asthenia—Risedronate—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Apraclonidine—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00285	0.00285	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Apraclonidine—Pruritus—Risedronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Apraclonidine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Apraclonidine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Apraclonidine—Diarrhoea—Risedronate—Paget's disease of bone	0.00273	0.00273	CcSEcCtD
Apraclonidine—Asthenia—Pamidronate—Paget's disease of bone	0.00272	0.00272	CcSEcCtD
Apraclonidine—Pruritus—Pamidronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Apraclonidine—Dizziness—Risedronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Apraclonidine—Diarrhoea—Pamidronate—Paget's disease of bone	0.00259	0.00259	CcSEcCtD
Apraclonidine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Apraclonidine—Vomiting—Risedronate—Paget's disease of bone	0.00253	0.00253	CcSEcCtD
Apraclonidine—Dermatitis—Risedronate—Paget's disease of bone	0.00251	0.00251	CcSEcCtD
Apraclonidine—Dizziness—Pamidronate—Paget's disease of bone	0.00251	0.00251	CcSEcCtD
Apraclonidine—Headache—Risedronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Apraclonidine—Asthenia—Zoledronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Apraclonidine—Pruritus—Zoledronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Apraclonidine—Vomiting—Pamidronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Apraclonidine—Dermatitis—Pamidronate—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Apraclonidine—Headache—Pamidronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Apraclonidine—Diarrhoea—Zoledronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Apraclonidine—Nausea—Risedronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Apraclonidine—Dizziness—Zoledronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Apraclonidine—Nausea—Pamidronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Apraclonidine—Vomiting—Zoledronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Apraclonidine—Dermatitis—Zoledronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Apraclonidine—Headache—Zoledronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Apraclonidine—Nausea—Zoledronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
